EG18231A - A process for the preparation of pharmaceutical compounds - Google Patents
A process for the preparation of pharmaceutical compoundsInfo
- Publication number
- EG18231A EG18231A EG449/87A EG44987A EG18231A EG 18231 A EG18231 A EG 18231A EG 449/87 A EG449/87 A EG 449/87A EG 44987 A EG44987 A EG 44987A EG 18231 A EG18231 A EG 18231A
- Authority
- EG
- Egypt
- Prior art keywords
- alkyl
- halo
- substituted
- hydrogen
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868619433A GB8619433D0 (en) | 1986-08-08 | 1986-08-08 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG18231A true EG18231A (en) | 1992-10-30 |
Family
ID=10602474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG449/87A EG18231A (en) | 1986-08-08 | 1987-08-02 | A process for the preparation of pharmaceutical compounds |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4983619A (pt) |
| EP (1) | EP0259972B1 (pt) |
| JP (1) | JPS63246364A (pt) |
| CN (1) | CN1021050C (pt) |
| AT (1) | ATE91489T1 (pt) |
| AU (1) | AU605498B2 (pt) |
| CA (1) | CA1290335C (pt) |
| DE (1) | DE3786507T2 (pt) |
| DK (1) | DK414087A (pt) |
| EG (1) | EG18231A (pt) |
| ES (1) | ES2058118T3 (pt) |
| GB (1) | GB8619433D0 (pt) |
| HU (1) | HU204520B (pt) |
| IL (1) | IL83433A (pt) |
| MX (1) | MX173324B (pt) |
| NZ (1) | NZ221353A (pt) |
| PH (1) | PH23488A (pt) |
| PT (1) | PT85477B (pt) |
| SU (1) | SU1593568A3 (pt) |
| ZA (1) | ZA875812B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
| US5494911A (en) * | 1990-05-18 | 1996-02-27 | Hoechst Aktiengesellschaft | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
| JPH06135948A (ja) * | 1992-10-30 | 1994-05-17 | Taiho Yakuhin Kogyo Kk | スチレン誘導体又はその塩 |
| CA2185448A1 (en) * | 1994-03-14 | 1995-09-21 | James L. Mulshine | Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents |
| JP2016537360A (ja) | 2013-11-22 | 2016-12-01 | ジェンザイム・コーポレーション | 神経変性疾患を治療するための新規な方法 |
| WO2021050556A1 (en) * | 2019-09-09 | 2021-03-18 | Rutgers, The State University Of New Jersey | Compositions and methods for inhibiting ribosome inactivating proteins |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
| DK545976A (da) * | 1975-12-11 | 1977-06-12 | Hoechst Ag | Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser |
| DE2655009A1 (de) * | 1976-12-04 | 1978-06-15 | Hoechst Ag | Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
| GB1598900A (en) * | 1978-05-23 | 1981-09-23 | Lilly Industries Ltd | Heterocyclic amino derivatives |
| FI71129C (fi) * | 1979-06-11 | 1986-11-24 | Ciba Geigy Ag | Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler |
| DE3331874A1 (de) * | 1982-09-13 | 1984-04-05 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue thiophenderivate |
| DE3609542A1 (de) * | 1986-03-21 | 1987-10-01 | Bayer Ag | 5-acylamino-pyrazol-derivate |
-
1986
- 1986-08-08 GB GB868619433A patent/GB8619433D0/en active Pending
-
1987
- 1987-08-02 EG EG449/87A patent/EG18231A/xx active
- 1987-08-03 PH PH35614A patent/PH23488A/en unknown
- 1987-08-04 IL IL83433A patent/IL83433A/xx not_active IP Right Cessation
- 1987-08-04 PT PT85477A patent/PT85477B/pt not_active IP Right Cessation
- 1987-08-05 CA CA000543738A patent/CA1290335C/en not_active Expired - Fee Related
- 1987-08-05 NZ NZ221353A patent/NZ221353A/en unknown
- 1987-08-06 DE DE87306989T patent/DE3786507T2/de not_active Expired - Fee Related
- 1987-08-06 ES ES87306989T patent/ES2058118T3/es not_active Expired - Lifetime
- 1987-08-06 EP EP87306989A patent/EP0259972B1/en not_active Expired - Lifetime
- 1987-08-06 ZA ZA875812A patent/ZA875812B/xx unknown
- 1987-08-06 SU SU874203115A patent/SU1593568A3/ru active
- 1987-08-06 MX MX007667A patent/MX173324B/es unknown
- 1987-08-06 AT AT87306989T patent/ATE91489T1/de active
- 1987-08-07 JP JP62198007A patent/JPS63246364A/ja active Pending
- 1987-08-07 DK DK414087A patent/DK414087A/da not_active Application Discontinuation
- 1987-08-07 CN CN87105515A patent/CN1021050C/zh not_active Expired - Fee Related
- 1987-08-07 AU AU76680/87A patent/AU605498B2/en not_active Ceased
- 1987-08-07 HU HU873600A patent/HU204520B/hu not_active IP Right Cessation
-
1990
- 1990-01-11 US US07/464,644 patent/US4983619A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0259972A2 (en) | 1988-03-16 |
| CA1290335C (en) | 1991-10-08 |
| AU7668087A (en) | 1988-02-11 |
| MX7667A (es) | 1993-09-01 |
| DE3786507T2 (de) | 1993-11-11 |
| EP0259972A3 (en) | 1990-05-02 |
| ATE91489T1 (de) | 1993-07-15 |
| ES2058118T3 (es) | 1994-11-01 |
| US4983619A (en) | 1991-01-08 |
| NZ221353A (en) | 1990-04-26 |
| DK414087D0 (da) | 1987-08-07 |
| ZA875812B (en) | 1989-04-26 |
| HU204520B (en) | 1992-01-28 |
| IL83433A0 (en) | 1988-01-31 |
| PT85477B (pt) | 1990-06-29 |
| EP0259972B1 (en) | 1993-07-14 |
| DE3786507D1 (de) | 1993-08-19 |
| MX173324B (es) | 1994-02-16 |
| SU1593568A3 (ru) | 1990-09-15 |
| HUT46684A (en) | 1988-11-28 |
| PH23488A (en) | 1989-08-16 |
| CN87105515A (zh) | 1988-03-23 |
| PT85477A (en) | 1987-09-01 |
| GB8619433D0 (en) | 1986-09-17 |
| DK414087A (da) | 1988-02-09 |
| CN1021050C (zh) | 1993-06-02 |
| JPS63246364A (ja) | 1988-10-13 |
| IL83433A (en) | 1992-03-29 |
| AU605498B2 (en) | 1991-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0610958A3 (en) | Intermediates for the preparation of derivatives of 4-oxoquinoline-3-carboxylic acid. | |
| PH25859A (en) | Composition for treatment of ischemic disorder | |
| SU1568886A3 (ru) | Cпocoб пoлучehия 1-фehил-3-haфtaлehилokcипpoпahamиhob или иx фapmakoлoгичeckи пpиemлemыx kиcлotho-aддиtиbhыx coлeй | |
| IL103944A0 (en) | Piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
| PL273728A1 (en) | Method for manufacturing arylic derivatives of the hydroxamic acid | |
| EP0228845A3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
| ZA891389B (en) | L-amino-3-acylquinoline derivatives their use as inhibitors of gastric secretion | |
| EG18231A (en) | A process for the preparation of pharmaceutical compounds | |
| PH24176A (en) | New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same | |
| IE56000B1 (en) | 1-arylcyclobutylalkylamine compounds | |
| HUT75647A (en) | Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia | |
| EP0446921A3 (en) | Optically active alkylene-dioxybenzene derivatives and their use in therapy | |
| IL74162A0 (en) | Naphthalene derivatives,their preparation and pharmaceutical compositions containing them | |
| ES8602764A1 (es) | Un procedimiento para preparar derivados de tiadiazina | |
| GR3000488T3 (en) | Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments | |
| ES2007784A6 (es) | Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea> | |
| HUT43930A (en) | Fungicides comprising naphthimidazolone derivatives as active substance and process for preparing the active substance | |
| MY102275A (en) | Antimykotische aminoazole ii | |
| ES8103092A1 (es) | Un procedimiento para la preparacion de derivados del acido aminodesoxi-clavulanico | |
| EP0271192A3 (en) | Purine histamine h1 antagonists, their preparation and pharmaceutical compositions containing them |